Skip to content
Monday, May 23, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Sun Pharma to launch Brillo, a first in class oral lipid lowering drug
  • Globus Medical announces first surgeries using Excelsius3D
  • Humana, private equity firm launch 2nd primary care joint venture for Medicare patients
  • Covax wants urgent action to close vaccine equity gap
  • Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa
  • Bayer to end CAR T-cell therapies collaboration with Atara Biotherapeutics
  • WHO validates CONVIDECIA as 11th vaccine for COVID-19
  • India’s drug regulator approves Boehringer Ingelheim’s cardiac treatment
  • CCI approves Covidshield Technologies, Biocon Biologics merger
  • Aster DM flies higher with Skye Air drone partnership
You are here
  • Home
  • South Korea

Tag: South Korea

Samsung Biologics shells US$2.3 bln to complete acquisition of Samsung Bioepis

22 April 202222 April 2022

SOUTH KOREA – Samsung Biologics has completed the US$2.3 billion acquisition of Biogen’s stake in the Samsung Bioepis joint venture. Samsung Biologics signed a stake acquisition agreement in January of…

Read More

SK Bioscience aims to become global biotech firm with new growth engine

1 April 20221 April 2022

SOUTH KOREA – SK Bioscience Co., a South Korean vaccine maker, has announced that it will broaden its business portfolio in order to secure a new growth engine, with the…

Read More

WHO establishes global biomanufacturing training hub in Korea

25 February 202225 February 2022

SOUTH KOREA – The World Health Organization (WHO), the Republic of Korea, and the WHO Academy have announced the creation of a global biomanufacturing training hub to serve all low-…

Read More

Samsung Biologics buys out Biogen in biosim venture for US$2.3B

31 January 202231 January 2022

SOUTH KOREA – Samsung Biologics announced that it has agreed to pay US$2.3 billion for Biogen’s stake in their nearly decade-long biosimilars joint venture Samsung Bioepis. The announcement follows a…

Read More

SK commits US$350M for the construction of global cell and gene therapy CDMO

17 January 202217 January 2022

SOUTH KOREA – SK Inc. of South Korea has committed US$350 million in equity financing to the Center for Breakthrough Medicines (CBM) as part of the organizations’ partnership announced two…

Read More

PDC*line Pharma raises US$20.3 million in Series B2 financing round

9 December 20219 December 2021

BELGIUM – PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, has completed its Series B2 round of funding, raising €17.5…

Read More

Roche’s arthritis drug scores EMA approval for treating severe Covid-19

7 December 20217 December 2021

NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…

Read More

Pfizer applies for emergency use authorization of its novel COVID-19 pill

18 November 202118 November 2021

USA – Pfizer, a US-based pharmaceutical giant has asked the Food and Drug Administration to approve its experimental COVID-19 pill for emergency use, setting the stage for a likely launch…

Read More

Merck’s oral antiviral pill grabs UK’s Emergency Use Approval in adults

4 November 20214 November 2021

UNITED KINGDOM – Britain has become the first country in the world to approve a potentially game-changing COVID-19 antiviral oral pill developed in collaboration by Merck and Ridgeback Biotherapeutics, providing…

Read More

Samsung Biologics rolls out the supply of domestically-manufactured Moderna vaccines in South Korea

28 October 202128 October 2021

SOUTH KOREA – Samsung Biologics, a major South Korean contract drug manufacturer, has rolled out supplies of the first batch of domestically-made Moderna vaccines. Moderna’s COVID-19 vaccine, manufactured by Samsung…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Sun Pharma to launch Brillo, a first in class oral lipid lowering drug

Globus Medical announces first surgeries using Excelsius3D

Humana, private equity firm launch 2nd primary care joint venture for Medicare patients

Covax wants urgent action to close vaccine equity gap

Health-tech Zuri Health secures US$1.3M in pre-seed round to expand operations across Africa

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

About 1 billion people globally denied access to assistive products: Report
https://t.co/XdBGynFqHM #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @WHO @UNICEF

Reply on Twitter 1527549390788902913Retweet on Twitter 15275493907889029131Like on Twitter 15275493907889029131Twitter 1527549390788902913
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

#Aenova Group invests US$11 mln to expand production of highly potent drugs in Germany
https://t.co/cRRWxBANAr #healthtech #innovation #healthcaredelivery #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1527546192435064832Retweet on Twitter 1527546192435064832Like on Twitter 1527546192435064832Twitter 1527546192435064832
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 20, 2022

Pollution caused 1 in 6 deaths globally for five years, study says
https://t.co/Wt2uRe1DHA #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #airpollution

Reply on Twitter 1527544485231607808Retweet on Twitter 1527544485231607808Like on Twitter 1527544485231607808Twitter 1527544485231607808
Retweet on TwitterHealthCare Africa Magazine Retweeted
OliveMugendaProf. Olive Mugenda Ph.D MGH@OliveMugenda·
May 18, 2022

The Cath-Lab at KUTRRH is now ready for commissioning. Cath-Lab is a specialised lab that deals with diagnosing blockages within the heart, unblocking as well as performing other interventions like cardiac pacemaker placements.
A great milestone for KUTRRH, MoH and Kenyans.

4
Reply on Twitter 1526921388057051137Retweet on Twitter 152692138805705113727Like on Twitter 1526921388057051137119Twitter 1526921388057051137
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.